Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011831

Chief Financial Officer sold 8,000 shares at $18.00 ($144,000)

  • Chief Financial Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-19 Exercise or conversion : show line 1 in the form +8,000 $5.20 $41,600 313,607 D
2019-02-19 Sale : show line 2 in the form −8,000 $18.00 $144,000 305,607 D
Open-market sales · 8,000 sh · avg $18.00 · $144,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-19 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −8,000 235,000 D
Loading xslF345X03/doc4.xml…